Committed to the highest standards of pharmacovigilance

At humanova, we hold a MedDRA (Medical Dictionary for Regulatory Activities) license, a key tool that significantly strengthens our pharmacovigilance processes by enabling the accurate standardization, coding, and validation of clinical information related to adverse events and other relevant medical data.

MedDRA is the globally standardized medical terminology widely used by the pharmaceutical industry and leading regulatory authorities worldwide for the coding, analysis, and monitoring of clinical and safety information.

This tool supports us in maintaining a more efficient, consistent, and robust management approach aligned with international regulatory requirements and the standards of the different countries where humanova operates.

Furthermore, the use of MedDRA enhances the interoperability and traceability of medical information within our processes, facilitating data analysis, early detection of safety signals, and effective communication with regulatory authorities, strategic partners, and healthcare professionals.

Having this tool reinforces our commitment to patient safety, quality, regulatory compliance, and operational excellence — fundamental pillars that allow us to continue evolving as a pharmaceutical corporation with a global vision.

At humanova, we continue to promote tools and processes that strengthen our response capabilities and contribute to transforming people’s health for the future we envision.